Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03676855
Other study ID # FWA000017585MD361/2017
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 31, 2018
Est. completion date March 31, 2019

Study information

Verified date September 2018
Source Ain Shams University
Contact hassan helmy, master
Phone 01023308711
Email saberaleek2222@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Comparison between bladder dissection at the beginning of cesarean section For morbidly adherent placenta and between delaying dissection until planning for cesarean hysterectomy


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date March 31, 2019
Est. primary completion date February 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

1. Women with BMI at or under 35 Kg/m2.

2. Women having previous two cesarean section or more.

3. Women with gestational age more than 32 weeks with viable fetus.

4. Women with any degree of placenta previa .

5. Patient with morbidly adherent placenta on cesarean scar only.

Exclusion Criteria:

1. Patient who are haemodynamically unstable before skin incision.

2. Patient with clinically evident intraamniotic infection.

3. Patient with previous history of bladder injury .

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
bladder dissection
Comparison between bladder dissection at the beginning of cesarean section For morbidly adherent placenta and between delaying dissection until planning for cesarean hysterectomy

Locations

Country Name City State
Egypt Ain Shams University Maternity Hospital Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Operative time of whole cs icluding all cs over the period of one year
Primary Blood loss through counting soaked towels and weighting them before and after being soaked considering the difference in grams as the calculated blood loss and calculating blood in the suction reservoir and comparing pre and post operative Hb level also haemotacrit level and number of units of packed RBCs transfused icluding all cs over the period of one year
Primary - Incidence of urological - Incidence of urological injuries discovered intraoperative and procedure needed to repair or as a late complication as fistula formation. during cs and post operative delayed complication icluding all cs over the period of one year
Secondary Neonatal APGAR score Neonatal APGAR score after delivery of the baby during the 1st 15 minutes
Secondary Time taken to create bladder flap from the start of bladder dissection from the start of bladder dissection icluding all cs over the period of one year
Secondary 3 months post operative filling cystometry 3 months post operative filling cystometry 3 months post operative
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05817448 - Hypoxia-induced Autophagy in the Pathogenesis of MAP
Active, not recruiting NCT02784886 - Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta N/A
Withdrawn NCT02635412 - Delivery Timing in Morbidly Adherent Placentas: a Randomized, Controlled Trial N/A
Completed NCT03416296 - Role of Ultrasound in Diagnosis of Placenta Previa and MAP
Recruiting NCT04938050 - Diagnostic Accuracy of a Specialized Pro Forma in Assessing Morbidly Adherent Placenta With Correlation to Intra-operative Findings
Completed NCT03976453 - Psychological Outcome of Women With Morbidly Adherent Placenta Following Hystrectomy
Recruiting NCT05307016 - Morbidly Adherent Placenta, Diagnosis and Proper Management